Good MorningEquities started the week on shaky footing and it looks like there will be no Santa Rally this year. The S&P 500 shed more than 1.0% at the low of the da making this the 5th consecutive day of selling and putting the index at the lowest level in over a month. Simply based on the chart action, it looks like the market made a quick about-face when it reached the 4,100 level in early December and now the selling is gaining momentum.
The driver of the move is inflation, the FOMC and the belief a recession is on the way. the takeaway for investors is the FOMC will have to curb economic activity in order to stop the growth of inflation and that can only lead to recession. In this light, the S&P 500 may not only retest the lows near 3,600 but continue downward well into next year and eventually retest the pandemic-induced lows of 2020. Featured: I interviewed 600 crypto millionaires – here's what's coming (Ad) 
|
Stocks | | |
It’s been a rough year for many stocks. And that includes several stocks that outperformed the market in 2021. One strategy that forward-thinking investors employ is to look for oversold stocks. One way to identify such stocks is by looking at a stock’s relative strength indicator... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | |
Heading into the week before Christmas, the United States Food and Drug Administration flagged Eli Lilly & Co. (NYSE: LLY) for a shortage of their new diabetes drug, Mounjaro. They are also having supply issues with their previous diabetes medicine, Trulicity, which is the pharmaceutical compa... Read the Full Story |
|
Markets | | |
Online pet products and services retailer Chewy, Inc. (NASDAQ: CHWY) stock has nearly doubled off its May 23, 2022, low of $22.22. The pandemic helped accelerate e-commerce usage and pet ownership, which are Chewy's wheelhouse. Once a pet is adopted or acquired, it has essential needs, including f... Read the Full Story |
|
|
Markets | | | European Union ministers on Monday finalized a long-awaited deal to implement a natural gas price cap they hope will help households and businesses better weather excessive price surges.
EU member countries failed to overcome their differences at previous emergency meetings, but sever... Read the Full Story |
|
Tech | | | Stocks edged lower in uncertain trading on Wall Street Monday as investors brace for higher interest rates from central banks to fight inflation.
The S&P 500 fell 0.2% as of 10:20 a.m. Eastern. The Dow Jones Industrial Average rose 60 points, or 0.2%, to 32,983 and the Nasdaq fell... Read the Full Story |
|
From Our PartnersWashington is running out of money…And guess where they'll look next?
When governments go broke, they take from the people.
It's happened before, and it's happening again.
The Department of Justice just admitted that cash isn't legally YOUR property. | | | Get your free guide now by clicking here >> |
|
Stocks | | | Wall Street racked up more losses Friday, as worries mounted that the Federal Reserve and other central banks are willing to bring on a recession if that’s what it takes to crush inflation.
The S&P 500 fell 1.1%, its third straight drop. The Dow Jones Industrial Average dropped 0.... Read the Full Story |
|
Stocks | | | Stocks are losing more ground on Wall Street in afternoon trading Friday as worries grow that the Federal Reserve and other central banks are willing to bring on a recession if that’s what it takes to get inflation under control.
The S&P 500 shed 1.6% as of 1:43 p.m. Eastern and i... Read the Full Story |
|
Markets | | |
One company that’s been in the headlines lately is Elon Musk’s “other” company Tesla, Inc. (NASDAQ: TSLA). The stock is down 57.35% so far this year, with many analysts attributing at least part of the decline to Musk being distracted with his purchase of Twitter.
In... Read the Full Story |
|
Markets | | | Donald Trump pledged to fix U.S. infrastructure as president. He vowed to take on China and bulk up American manufacturing. He said he would reduce the budget deficit and make the wealthy pay their fair share of taxes.
Yet after two years as president, it's Joe Biden who is acting on ... Read the Full Story |
|
Markets | | |
If you want to know why Madrigal Pharmaceuticals (NASDAQ: MDGL) is up 200% in one day, it's because the company released the results of a late-stage trial for one of its compounds. The compound, resmetirom, is intended for treating liver ailments and has been found to be effective in treating non-... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. | | View Today's Stock Pick |
|
